Amgen Inc.
AMGN
$277.29
-$5.35-1.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 11.27% | 24.48% | 20.32% | 21.76% | 19.55% |
| Total Other Revenue | 1.93% | -0.85% | 14.52% | 27.03% | 26.48% |
| Total Revenue | 10.86% | 23.18% | 20.07% | 21.98% | 19.84% |
| Cost of Revenue | -71.01% | 83.28% | 78.49% | 86.05% | 40.58% |
| Gross Profit | 45.89% | 1.88% | -0.41% | -3.15% | 12.73% |
| SG&A Expenses | 5.09% | 20.10% | 37.94% | 43.72% | 13.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 108.35% | -91.91% | -101.90% | -- | -1,441.38% |
| Total Operating Expenses | -12.40% | 28.24% | 49.50% | 59.91% | 6.34% |
| Operating Income | 47.23% | 9.61% | -27.77% | -52.01% | 49.53% |
| Income Before Tax | -8.22% | 59.27% | -50.81% | -101.98% | -51.26% |
| Income Tax Expenses | 82.35% | 24.88% | -79.57% | -92.51% | -35.61% |
| Earnings from Continuing Operations | -18.25% | 63.58% | -45.90% | -103.98% | -52.54% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.25% | 63.58% | -45.90% | -103.98% | -52.54% |
| EBIT | 47.23% | 9.61% | -27.77% | -52.01% | 49.53% |
| EBITDA | 35.04% | 24.59% | -6.61% | -19.43% | 45.56% |
| EPS Basic | -18.55% | 62.98% | -46.10% | -103.96% | -52.54% |
| Normalized Basic EPS | 74.76% | -14.42% | -38.49% | -78.66% | 18.54% |
| EPS Diluted | -18.73% | 62.11% | -46.30% | -103.99% | -52.42% |
| Normalized Diluted EPS | 74.77% | -14.74% | -38.72% | -78.50% | 18.32% |
| Average Basic Shares Outstanding | 0.37% | 0.37% | 0.37% | 0.37% | 0.00% |
| Average Diluted Shares Outstanding | 0.37% | 0.74% | 0.74% | -0.37% | 0.19% |
| Dividend Per Share | 5.63% | 5.63% | 5.63% | 5.63% | 9.79% |
| Payout Ratio | 0.29% | -0.35% | 0.96% | -27.71% | 1.31% |